{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of PLX-PAD in Chronic Limb-Threatening Ischaemia"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "parallel-group, placebo-controlled trial enrolled 213 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients with chronic limb-threatening ischaemia (CLTI) who are not candidates for revascularization"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 2:1 to receive PLX-PAD or placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "assessed whether PLX-PAD could improve amputation-free survival (AFS)"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was AFS, defined as the time from randomisation to major amputation or death, assessed over 12-36 months."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation used permuted blocks, and allocation was concealed via an interactive web-based system."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included patients, clinicians, and outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From September 2017 to November 2020, 143 patients were randomised to PLX-PAD and 70 to placebo"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "205 patients analysed using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "HR 0.93, 95% CI 0.53 to 1.63; P = 0.788"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events occurred in 73.5% of PLX-PAD and 82.6% of placebo patients"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT03006770; EudraCT 2015-005532-18."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 24,
    "max_score": 25
  },
  "model": "gpt-4o"
}